Application for Blocklisting

PuriCore plc

 ("PuriCore" or the "Company")

7 February 2013

Blocklisting Application

PuriCore plc (LSE: PURI), the water-based clean technology company, announces that application has today been made to the UK Listing Authority for the blocklisting of, and to the London Stock Exchange for the admission of, 547,079 ordinary shares of 10p each to be admitted to the Official List. 

The block admission relates to ordinary shares that will be allotted from time to time in accordance with the exercise of warrants issued by the Company and will rank pari passu with the existing ordinary shares in issue. It is anticipated that admission will take place on 15 February 2013.

Enquiries:

UK

FTI Consulting

Susan Stuart/Simon Conway

Victoria Foster Mitchell

+44 (0) 20 7831 3113

About PuriCore

PuriCore plc (LSE: PURI) is a water-based clean technology company focused on developing and commercialising proprietary solutions that protect people from the spread of infectious pathogens without causing harm to human health or the environment. The Company's products are used in a broad range of markets that depend upon effective pathogen control. PuriCore is the leading full provider of all products and services required for a safe, efficient, and compliant endoscope decontamination to protect patients in UK hospitals. The Company's products are the standard for food safety and are used for floral care in leading US supermarket chains. PuriCore also offers a breakthrough wound therapy solution to treat chronic and acute wounds including diabetic ulcers and burns. PuriCore is headquartered in Malvern, Pennsylvania, with operations in Stafford and Clevedon, UK. To receive additional information on PuriCore, visit www.puricore.com, which does not form part of this announcement.